Atlas Trials

Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia

Clinical trial NCT03131986 · UNKNOWN

Trial details

NCT number
NCT03131986
Sponsor
The University of Hong Kong
Status
UNKNOWN
Study type
OBSERVATIONAL
Leukemia, Myelogenous, Chronic Phase
Start date
2017-04-18
Primary completion
2019-03-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.